Business Description
Vistagen Therapeutics is a South San Francisco-based company founded in 1998 that focuses on developing new medicines for mental health and brain-related conditions. Its most advanced treatments are delivered through nasal sprays and work by targeting natural signaling pathways in the body, with several candidates currently in mid- to late-stage clinical trials addressing conditions such as social anxiety, depression, menopausal symptoms, and appetite loss. The company also has a partnership with AffaMed Therapeutics to bring one of its key treatments to patients across multiple markets.
